For development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump ...

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) shares are up Monday after the company announced an exclusive worldwide ...

EKSO BIONICS (EKSO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula ...

EKSO stock results show that Ekso Bionics Holdings missed analyst estimates for earnings per share and missed on revenue for ...

SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader ...

Ekso Bionics will be reporting Q1 earnings on April 29.Wall Street analysts expect Ekso Bionics will report losses per share of $0.160.Follow ...

SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $3.4 million in its first quarter. The San Rafael, California-based company said it ...

Scott Davis; Chief Executive Officer, Director; Ekso Bionics Holdings Inc Jerome Wong; Chief Financial Officer; Ekso Bionics Holdings Inc Matt Steinberg; IR; Lazar FINN Partners Sean Lee; Analyst; H.C ...

Xeris and Beta Bionics today announced an exclusive worldwide collaboration to develop a glucagon product for proprietary pump technology.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia ...

SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $3.4 million in its first quarter. The San Rafael, California-based company ...